Sector
PharmaceuticalsOpen
₹0.8Prev. Close
₹0.78Turnover(Lac.)
₹0.3Day's High
₹0.81Day's Low
₹0.7552 Week's High
₹052 Week's Low
₹0Book Value
₹17.21Face Value
₹10Mkt Cap (₹ Cr.)
0.66P/E
0EPS
0Divi. Yield
0No Record Found
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 | Mar-2010 | Mar-2009 |
---|---|---|---|---|
Equity Capital | 8.2 | 8.2 | 8.2 | 8.2 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 10.36 | 10.54 | 11.13 | 32.01 |
Net Worth | 18.56 | 18.74 | 19.33 | 40.21 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
---|---|---|
Revenue | 0 | 0.04 |
yoy growth (%) | -100 | |
Raw materials | 0 | -0.07 |
As % of sales | 0 | 168.76 |
Employee costs | -0.01 | -0.12 |
Y/e 31 Mar( In .Cr) | Mar-2012 | Mar-2011 |
---|---|---|
Profit before tax | -0.17 | -0.59 |
Depreciation | -0.06 | -0.06 |
Tax paid | 0 | 0 |
Working capital | 0.07 | |
Other operating items |
Y/e 31 Mar | Mar-2012 | Mar-2011 |
---|---|---|
Growth matrix (%) | ||
Revenue growth | -100 | |
Op profit growth | -78.11 | |
EBIT growth | -70.28 | |
Net profit growth | -70.06 |
Particulars (Rupees in Crores.) | Mar-2016 | Mar-2015 | Mar-2014 | Mar-2013 | Mar-2012 |
---|---|---|---|---|---|
Gross Sales | 0 | 0 | 0 | 0 | 0 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 0 | 0 | 0 | 0 | 0 |
Other Operating Income | 0.01 | 0.01 | 0 | 0 | 0 |
Other Income | 0 | 0 | 0 | 0 | 0 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceuticals Industries Ltd SUNPHARMA | 1,808.2 | 157.37 | 4,33,847.75 | 863.29 | 0.75 | 5,123.67 | 98.33 |
Divis Laboratories Ltd DIVISLAB | 6,250.2 | 90.32 | 1,65,923.17 | 518 | 0.48 | 2,302 | 513.62 |
Cipla Ltd CIPLA | 1,508.1 | 28.77 | 1,21,796.04 | 1,178.16 | 0.86 | 3,969.86 | 360.73 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,338.4 | 69.06 | 1,12,981.55 | 460 | 0.84 | 2,376 | 222.38 |
Mankind Pharma Ltd MANKIND | 2,615.3 | 52.27 | 1,04,785.17 | 634.43 | 0 | 2,529.74 | 269.23 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
K O Isaac
Director
G Subramanian
Director
V M Sankaran Nampoothiri
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by ABL Bio-Technologies Ltd
Summary
ABL Bio Technologies Limited (ABL) is an India-based biotechnology company. The Company operates in three segments: formulation, research and development and the Docosahexaenoic acid (DHA) project. The Company focuses on discovery, collection of microbes, establishment of compound libraries, discovery of drug and nutrition targets and conducting research and converting the strains/compounds in to deliverable active pharmaceutical products. ABL Biotechnologies was incorporated in the year 1992. ABL is engagaed in identification and commercial extraction of bio-chemicals, predominantly from microbes, that are used as nutritional, cosmetic, pharmaceutical, and industrial intermediates.Companys R&D unit is located at Vishakapatnam that has been recognised by the Department of Scientific and Industrial Research, Ministry of Science and Technology, Government of India.Companys microbial metabolites laboratory located at Chennai is focused on evaluating new sources of biochemicals from marine organisms.Company has collaborated with institutions such as the National Facility for Marine Cyanobacteria, Bharathidasan University, Trichy, the National Institute of Oceanography, The Madras University and the Dr.A.L.M Post Graduate Institute of Medical Sciences, Madras to introduce joint development programmes of advanced research in India.Company has taken various initiatives such as sale or licensing of technologies, development of biochemical intermediates, conducting research on aquatic
Read More
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice